» Articles » PMID: 39273535

Glial Cells As Key Regulators in Neuroinflammatory Mechanisms Associated with Multiple Sclerosis

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Sep 14
PMID 39273535
Authors
Affiliations
Soon will be listed here.
Abstract

Even though several highly effective treatments have been developed for multiple sclerosis (MS), the underlying pathological mechanisms and drivers of the disease have not been fully elucidated. In recent years, there has been a growing interest in studying neuroinflammation in the context of glial cell involvement as there is increasing evidence of their central role in disease progression. Although glial cell communication and proper function underlies brain homeostasis and maintenance, their multiple effects in an MS brain remain complex and controversial. In this review, we aim to provide an overview of the contribution of glial cells, oligodendrocytes, astrocytes, and microglia in the pathology of MS during both the activation and orchestration of inflammatory mechanisms, as well as of their synergistic effects during the repair and restoration of function. Additionally, we discuss how the understanding of glial cell involvement in MS may provide new therapeutic targets either to limit disease progression or to facilitate repair.

Citing Articles

NLRP3 inflammasome in neuroinflammation and central nervous system diseases.

Xu W, Huang Y, Zhou R Cell Mol Immunol. 2025; .

PMID: 40075143 DOI: 10.1038/s41423-025-01275-w.


The Crucial Role of the Blood-Brain Barrier in Neurodegenerative Diseases: Mechanisms of Disruption and Therapeutic Implications.

Kim S, Jung U, Kim S J Clin Med. 2025; 14(2).

PMID: 39860392 PMC: 11765772. DOI: 10.3390/jcm14020386.


Oligodendrocytes, the Forgotten Target of Gene Therapy.

Ozgur-Gunes Y, Le Stunff C, Bougneres P Cells. 2024; 13(23).

PMID: 39682723 PMC: 11640421. DOI: 10.3390/cells13231973.


SIRT6 modulates lesion microenvironment in LPC induced demyelination by targeting astrocytic CHI3L1.

Du J, Yin Y, Wu D, Diao C, Zhao T, Peng F J Neuroinflammation. 2024; 21(1):243.

PMID: 39342313 PMC: 11438192. DOI: 10.1186/s12974-024-03241-1.

References
1.
Kunkl M, Frascolla S, Amormino C, Volpe E, Tuosto L . T Helper Cells: The Modulators of Inflammation in Multiple Sclerosis. Cells. 2020; 9(2). PMC: 7072830. DOI: 10.3390/cells9020482. View

2.
Zveik O, Rechtman A, Brill L, Vaknin-Dembinsky A . Anti- and pro-inflammatory milieu differentially regulate differentiation and immune functions of oligodendrocyte progenitor cells. Immunology. 2024; 171(4):618-633. DOI: 10.1111/imm.13757. View

3.
Ghorbani S, Jelinek E, Jain R, Buehner B, Li C, Lozinski B . Versican promotes T helper 17 cytotoxic inflammation and impedes oligodendrocyte precursor cell remyelination. Nat Commun. 2022; 13(1):2445. PMC: 9068758. DOI: 10.1038/s41467-022-30032-0. View

4.
Prajeeth C, Lohr K, Floess S, Zimmermann J, Ulrich R, Gudi V . Effector molecules released by Th1 but not Th17 cells drive an M1 response in microglia. Brain Behav Immun. 2014; 37:248-59. DOI: 10.1016/j.bbi.2014.01.001. View

5.
Zhong Z, Umemura A, Sanchez-Lopez E, Liang S, Shalapour S, Wong J . NF-κB Restricts Inflammasome Activation via Elimination of Damaged Mitochondria. Cell. 2016; 164(5):896-910. PMC: 4769378. DOI: 10.1016/j.cell.2015.12.057. View